- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2662-8651
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Development of therapeutic antibodies for the treatment of diseases ; volume:3 ; number:1 ; day:22 ; month:11 ; year:2022 ; pages:1-31 ; date:12.2022
Molecular biomedicine ; 3, Heft 1 (22.11.2022), 1-31, 12.2022
- Creator
-
Wang, Zeng
Wang, Guoqing
Lu, Huaqing
Li, Hongjian
Tang, Mei
Tong, Aiping
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s43556-022-00100-4
- URN
-
urn:nbn:de:101:1-2023020409065834026253
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wang, Zeng
- Wang, Guoqing
- Lu, Huaqing
- Li, Hongjian
- Tang, Mei
- Tong, Aiping
- SpringerLink (Online service)
Other Objects (12)
Development of therapeutic antibodies for the treatment of diseases
Therapeutic potential of CD20/CD3 bispecific antibodies in the treatment of autoimmune diseases
Handbook of therapeutic antibodies, Vol. 3.. Approved therapeutic antibodies
Glycoengineering of Therapeutic Antibodies
Therapeutic antibodies for the prevention and treatment of cancer
Development of therapeutic vaccines for the treatment of diseases
Therapeutic antibodies
Therapeutic antibodies
Targeting MICA with therapeutic antibodies for the treatment of cancer
Individualized Dosing of Therapeutic Monoclonal Antibodies—a Changing Treatment Paradigm?
Handbook of therapeutic antibodies, Vol. 2.. Clinical development of antibodies
Handbook of therapeutic antibodies, Vol. 4.. Approved therapeutic antibodies and in vivo diagnostics
Development of therapeutic antibodies for the treatment of diseases
Therapeutic potential of CD20/CD3 bispecific antibodies in the treatment of autoimmune diseases
Handbook of therapeutic antibodies, Vol. 3.. Approved therapeutic antibodies
Glycoengineering of Therapeutic Antibodies
Therapeutic antibodies for the prevention and treatment of cancer
Development of therapeutic vaccines for the treatment of diseases
Therapeutic antibodies
Therapeutic antibodies
Targeting MICA with therapeutic antibodies for the treatment of cancer
Individualized Dosing of Therapeutic Monoclonal Antibodies—a Changing Treatment Paradigm?
Handbook of therapeutic antibodies, Vol. 2.. Clinical development of antibodies
Handbook of therapeutic antibodies, Vol. 4.. Approved therapeutic antibodies and in vivo diagnostics
Development of therapeutic antibodies for the treatment of diseases
Therapeutic potential of CD20/CD3 bispecific antibodies in the treatment of autoimmune diseases
Handbook of therapeutic antibodies, Vol. 3.. Approved therapeutic antibodies
Glycoengineering of Therapeutic Antibodies
Therapeutic antibodies for the prevention and treatment of cancer
Development of therapeutic vaccines for the treatment of diseases
Therapeutic antibodies
Therapeutic antibodies
Targeting MICA with therapeutic antibodies for the treatment of cancer
Individualized Dosing of Therapeutic Monoclonal Antibodies—a Changing Treatment Paradigm?
Handbook of therapeutic antibodies, Vol. 2.. Clinical development of antibodies